GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2013

Targeting Tau Protein Release Offers Hope for Alzheimer’s Patients

  • Researchers from King's College London say that neuronal activity can stimulate tau release from healthy neurons in the absence of cell death. The results published by Diane Hanger, Ph.D., and her colleagues in EMBO reports show that treatment of neurons with known biological signaling molecules increases the release of tau into the culture medium. The release of tau from cortical neurons is therefore a physiological process that can be regulated by neuronal activity.

    Tau proteins stabilize microtubules, the long threads of polymers that help to maintain the structure of the cell. However, in Alzheimer's disease or certain types of dementia, tau accumulates in neurons or glial cells, where it contributes to neurodegeneration.

    In addition to intracellular aggregation, recent experiments have shown that tau is released from neuronal cells and taken up by neighboring cells, which allows the spread of aggregated tau across the brain. This release could occur passively from dying neuronal cells, though some evidence suggests it might take place before neuronal cell death and neurodegeneration. The new findings indicate that tau release is an active process in healthy neurons, and this could be altered in diseased brains.

    "Our findings suggest that altered tau release is likely to occur in response to changes in neuronal excitability in the Alzheimer's brain. Secreted tau could therefore be involved in the propagation of tau pathology in tauopathies, a group of neurodegenerative diseases associated with the accumulation of tau proteins in the brain," explains Dr. Hanger, reader in the department of neuroscience at King's College London. In these experiments, Amy Pooler, Ph.D., the lead author, revealed that molecules such as potassium chloride, glutamate, or an AMPA receptor agonist could release tau from cortical neurons in an active physiological process that is at least partially dependent on presynaptic vesicle secretion.

    The new findings by the scientists indicate that tau has previously unknown roles in biological signaling between cells, in addition to its well-established role in stabilizing microtubules.

    "We believe that targeting the release of tau could be explored as a new therapeutic approach for the treatment of Alzheimer's disease and related tauopathies," said Dr. Hanger. Additional studies are needed in model organisms to test this hypothesis further.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?